4.6 Article

The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor

Cecylia S. Lupala et al.

Summary: The COVID-19 pandemic caused by SARS-CoV-2 virus has resulted in over 270 million infections and 5.3 million deaths worldwide. The emergence of the Omicron variant has raised concerns about reducing vaccine efficacy and neutralizing antibodies due to its numerous mutations. Analysis indicates that the Omicron variant binds more strongly to the human ACE2 protein, with mutations at the ACE2-RBD interface enhancing tight binding through increased hydrogen bonding interactions and enlarged buried solvent accessible surface area.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Emerging mutation patterns in SARS-CoV-2 variants

David A. Ostrov et al.

Summary: It is urgent to understand the functional effects of mutations in emerging variants of SARS-CoV-2. Variants of concern and emerging variants of interest exhibit four patterns of spike glycoprotein mutations that enhance transmissibility and immune evasion. These defined patterns provide a basis for the development of next line antiviral drugs and vaccine candidates.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Review Virology

Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines

Yusha Araf et al.

Summary: The Omicron variant of SARS-CoV-2 is a heavily mutated virus with a high risk of infection. Limited information is available regarding the genomics, transmissibility, and effectiveness of vaccines against this variant, emphasizing the need for further investigation.

JOURNAL OF MEDICAL VIROLOGY (2022)

Review Immunology

Proteolytic activation of SARS-CoV-2 spike protein

Makoto Takeda

Summary: This review discusses the crucial role of S protein cleavage in coronavirus infection, particularly focusing on SARS-CoV-2. The complexity of the cleavage activation mechanism of the S protein is highlighted, with different cleavage sites and motifs involved. Variants of concern with enhanced infectivity have emerged during the ongoing pandemic, demonstrating the significant impact of changes in S protein cleavability on viral infectivity and virulence.

MICROBIOLOGY AND IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Evolution of enhanced innate immune evasion by SARS-CoV-2

Lucy G. Thorne et al.

Summary: The Alpha variant of SARS-CoV-2 effectively suppresses innate immune responses in airway epithelial cells compared to first-wave isolates, possibly due to increased expression of specific viral antagonist proteins. This enhanced innate immune suppression may increase the likelihood of successful transmission of the Alpha variant and potentially impact in vivo replication and infection duration. Mutations outside the spike coding region, such as those observed in the N and Orf9b regulatory regions, play a crucial role in the adaptation of SARS-CoV-2 variants to humans.

NATURE (2022)

Review Cell Biology

Mechanisms of SARS-CoV-2 entry into cells

Cody B. Jackson et al.

Summary: The entry of SARS-CoV-2 into host cells is facilitated by the interaction between the viral spike protein and ACE2, leading to virus-cell membrane fusion, which has been extensively studied at the structural and cellular levels worldwide. This understanding has paved the way for the development of effective vaccines in response to the COVID-19 pandemic, caused by the infection with SARS-CoV-2.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)

Article Infectious Diseases

Increased transmissibility of the alpha SARS-CoV-2 variant: evidence from contact tracing data in Oslo, January to February 2021

Jonas Christoffer Lindstrom et al.

Summary: The study suggests that households are the primary locations for rapid transmission of the new lineage alpha. Cases infected with the alpha lineage had a 60% increase in secondary attack rate within households compared to other variants, and a 24% increase in overall secondary attack rate among all close contacts.

INFECTIOUS DISEASES (2022)

Article Virology

IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection

Massimo Palatini et al.

Summary: This study identified IFITM3 as a novel protein-protein interaction partner of NTCP, which significantly affects the infection of HBV and HDV in hepatoma cells and primary human hepatocytes expressing NTCP. However, the specific mechanism by which this interaction facilitates the infection process remains unknown.

VIRUSES-BASEL (2022)

Article Cell Biology

Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant

Yang Liu et al.

Summary: This study reports that the P681R mutation in the Delta spike plays a crucial role in the replacement of the Alpha variant by the Delta variant during the COVID-19 pandemic. The Delta variant outcompetes the Alpha variant in human lung cells and airway tissues. The P681R mutation enhances the cleavage of the spike protein, leading to increased replication of the Delta variant.

CELL REPORTS (2022)

Article Microbiology

Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein

Mizuki Yamamoto et al.

Summary: The study found that the cell surface entry pathway of SARS-CoV-2 includes a metalloproteinase-mediated pathway in addition to the TMPRSS2 and endosomal pathways. The metalloproteinase-mediated pathway requires prior cleavage of the spike protein into two domains, a condition met by SARS-CoV-2 but not by the related human coronavirus SARS-CoV. Additionally, inhibiting metalloproteins was crucial in preventing cell death, which may lead to organ damage. The findings provide new insights into the unique pathogenesis of COVID-19 and are relevant to the development of effective therapies.
Article Biology

Low dose inocula of SARS-CoV-2 Alpha variant transmits more efficiently than earlier variants in hamsters

Bobo Wing-Yee Mok et al.

Summary: The study found that the Alpha variant of SARS-CoV-2 has increased competitive fitness in a hamster model, replicating and shedding more efficiently in the nasal cavity, which may contribute to its rapid transmission. These results help explain why emerging variants of the virus are more efficient in spreading.

COMMUNICATIONS BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Opposing activities of IFITM proteins in SARS-CoV-2 infection

Guoli Shi et al.

Summary: The study reveals that some IFITMs can restrict SARS-CoV-2 infections while others enhance infections, with IFITM3 showing new antiviral mechanisms involving amphipathic helix and endocytosis-promoting motif. These findings provide insights into the dual roles of IFITM3 in enhancing viral infection at the plasma membrane and restricting endosomal SARS-CoV-2.

EMBO JOURNAL (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation

Maaran Michael Rajah et al.

Summary: Severe cases of COVID-19 are associated with lung abnormalities, notably the presence of syncytial pneumocytes. New variants of the virus, such as Alpha and Beta, have shown an increased ability to form larger and more numerous syncytia compared to the ancestral strain D614G. The spike proteins of these variants also display higher affinity for the ACE2 receptor and can be inhibited by interferon-induced transmembrane proteins. Individual mutations in the spike proteins affect fusogenicity, ACE2 binding, and recognition by monoclonal antibodies. Additionally, the Delta variant spike protein has been found to trigger faster fusion than the D614G strain, indicating an enhanced syncytia formation capability in emerging SARS-CoV-2 variants.

EMBO JOURNAL (2021)

Article Virology

A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein

Sylvie Roy et al.

Summary: The codon optimized S protein of SARS-CoV-2 can migrate to the cell membrane. Efficient production of MLV infectious viral particles was achieved with stable expression of a shorter Delta S version. Delta S was 15-times more efficiently incorporated into VLPs compared to S, showing potential for immunization strategies for COVID-19.

VIRUS RESEARCH (2021)

Article Microbiology

Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland

Ana da Silva Filipe et al.

Summary: Genomic epidemiology analysis revealed multiple introductions of SARS-CoV-2 into Scotland from mainland Europe, especially Italy and Spain, during the first wave of COVID-19. Early introductions led to community outbreaks, healthcare facility transmission, and an outbreak at an international conference. Earlier implementation of travel restrictions and quarantine measures could have reduced the number of COVID-19 cases in Scotland.

NATURE MICROBIOLOGY (2021)

Article Microbiology

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

Xiaoying Shen et al.

Summary: Current COVID-19 vaccines target the ancestral SARS-CoV-2 spike, but the emerging B.1.1.7 variant with multiple spike mutations may impact some antibody therapies while posing no major concerns for vaccine efficacy or increased risk of reinfection.

CELL HOST & MICROBE (2021)

Article Virology

The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2

Helena Winstone et al.

Summary: The presence of a polybasic cleavage site in the spike protein of SARS-CoV-2 allows the virus to enter cells in a pH-independent manner, mitigating against IFITM-mediated restriction and promoting replication and transmission. Targeted depletion of IFITM2 expression alleviates potent inhibition of SARS-CoV-2 replication by type I IFNs. Therapeutic strategies targeting furin-mediated cleavage of the spike protein may reduce viral replication through the activity of type I IFNs.

JOURNAL OF VIROLOGY (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 evolution during treatment of chronic infection

Steven A. Kemp et al.

Summary: Chronic infection with SARS-CoV-2 can lead to viral evolution and increased resistance to neutralizing antibodies in immunosuppressed individuals treated with convalescent plasma. During convalescent plasma therapy, there were significant shifts in the viral population structure and sensitivity, suggesting strong selection pressure on the virus during treatment.

NATURE (2021)

Editorial Material Immunology

Clash of the titans: interferons and SARS-CoV-2

Nolwenn Jouvenet et al.

Summary: The article discusses the role of interferons in combating viruses and how viral effector proteins can impact interferon responses. It also highlights unresolved questions that need further exploration to better understand the battle between interferons and SARS-CoV-2.

TRENDS IN IMMUNOLOGY (2021)

News Item Medicine, General & Internal

Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Biochemistry & Molecular Biology

A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research

Suzannah J. Rihn et al.

Summary: The report introduces a range of tools for SARS-CoV-2 research, including a single plasmid reverse genetics system, a panel of antibodies, clinical isolates, and permissive cell lines. These tools have the potential to advance COVID-19 vaccine design, drug testing, and discovery science.

PLOS BIOLOGY (2021)

Article Immunology

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant

Carl Graham et al.

Summary: The interaction between the SARS-CoV-2 Spike receptor binding domain (RBD) and the host cell receptor ACE2 is crucial for viral entry, with RBD being the main target for neutralizing antibodies. Mutations in RBD, N-terminal domain (NTD), and S2 subunits of Spike have been found in circulating SARS-CoV-2 variants. This study isolates and characterizes monoclonal antibodies targeting different epitopes on RBD, NTD, and S2 to understand how these mutations affect antigenicity and neutralization resistance.

IMMUNITY (2021)

Article Microbiology

The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets

Thomas P. Peacock et al.

Summary: Efficient transmission of SARS-CoV-2 among infected ferrets is dependent on a functional furin cleavage site in the spike protein. The virus has a selective advantage in lung cells and primary human airway epithelial cells due to a polybasic insertion, but replication may be impaired in certain cell lines.

NATURE MICROBIOLOGY (2021)

Article Virology

Cytoplasmic Tail Truncation of SARS-CoV-2 Spike Protein Enhances Titer of Pseudotyped Vectors but Masks the Effect of the D614G Mutation

Hsu-Yu Chen et al.

Summary: The high pathogenicity of SARS-CoV-2 requires handling under biosafety level 3 conditions. Spike protein-pseudotyped vectors are useful for studying viral entry and inhibition, with methods to increase titer commonly including ultracentrifugation and Spike protein tail truncation. Studies showed that truncating the Spike tail increased incorporation into vectors and enhanced titers without impacting sensitivity to neutralization, while the D614G mutation independently increased incorporation and titers but was masked by the truncation. Use of full-length Spike protein with tangential flow filtration is recommended for generating high titer pseudotyped vectors retaining native Spike protein functions.

JOURNAL OF VIROLOGY (2021)

Article Multidisciplinary Sciences

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas et al.

Summary: The SARS-CoV-2 B.1.617 Delta variant, first identified in India in 2020, has become dominant in some regions and is spreading to many countries. This variant shows resistance to certain monoclonal antibodies and antibodies in convalescent sera, as well as reduced neutralization by some COVID-19 vaccines. Administration of two doses of the vaccine is needed for a neutralizing response against the Delta variant.

NATURE (2021)

Editorial Material Medicine, General & Internal

SARS-CoV-2 Variants in Patients with Immunosuppression

Lawrence Corey et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Microbiology

Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains

Enya Qing et al.

Summary: Adaptive changes in the coronavirus spike proteins, especially in the N-terminal domains, can increase SARS-CoV-2 spike protein-mediated membrane fusion and cell entry, leading to amplified virus-cell binding. However, these changes may also reduce interdomain associations, making spike proteins susceptible to irreversible inactivation on virus-like particles.
Article Multidisciplinary Sciences

IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro

Caterina Prelli Bozzo et al.

Summary: IFITM proteins can restrict viral pathogens, but they also support efficient infection of SARS-CoV-2 in human lung cells. The spike protein of SARS-CoV-2 interacts with IFITMs and hijacks them for viral infection, making IFITM proteins potential therapeutic targets for inhibiting virus entry and replication.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

Bo Meng et al.

Summary: The Delta H69N70 mutation in SARS-CoV-2 spike protein increases infectivity and partially rescues immune escape mutations that impair infectivity. Continued surveillance and research on deletions with functional effects are necessary.

CELL REPORTS (2021)

Article Environmental Sciences

Increased Transmissibility of the SARS-CoV-2 Alpha Variant in a Japanese Population

Hideo Tanaka et al.

Summary: A study in Japan revealed that the SARS-CoV-2 Alpha variant has a transmission capability approximately 1.9-2.3 times higher than the pre-existing virus, resulting in a significantly increased secondary attack rate in household contacts.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Biochemistry & Molecular Biology

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

Markus Hoffmann et al.

MOLECULAR CELL (2020)

Article Multidisciplinary Sciences

Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform

Tran Thi Nhu Thao et al.

NATURE (2020)

Article Biotechnology & Applied Microbiology

Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System

Ruodan Xu et al.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)

Article Multidisciplinary Sciences

Neuropilin-1 is a host factor for SARS-CoV-2 infection

James L. Daly et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Ludovico Cantuti-Castelvetri et al.

SCIENCE (2020)

Review Microbiology

From Entry to Egress: Strategic Exploitation of the Cellular Processes by HIV-1

Pavitra Ramdas et al.

FRONTIERS IN MICROBIOLOGY (2020)

Article Microbiology

Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction

Toshana L. Foster et al.

Cell Host & Microbe (2016)

Article Multidisciplinary Sciences

Interferon induction of IFITM proteins promotes infection by human coronavirus OC43

Xuesen Zhao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Virology

Interferon-stimulated genes: roles in viral pathogenesis

John W. Schoggins

CURRENT OPINION IN VIROLOGY (2014)

Article Virology

IFITM-Family Proteins: The Cell's First Line of Antiviral Defense

Charles C. Bailey et al.

ANNUAL REVIEW OF VIROLOGY, VOL 1 (2014)

Article Virology

Relative resistance of HIV-1 founder viruses to control by interferon-alpha

Angharad E. Fenton-May et al.

RETROVIROLOGY (2013)